Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.280
-0.070 (-1.61%)
At close: Apr 28, 2026, 4:00 PM EDT
4.400
+0.120 (2.80%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $158.33 million as of April 28, 2026. Its market cap has increased by 14.63% in one year.
Market Cap
158.33M
Enterprise Value
45.03M
1-Year Change
14.63%
Ranking
Category
Stock Price
$4.28
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $158.33M, a decrease of -73.41%. That is a compound annual growth rate of -14.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 165.34M |
| Oramed Pharmaceuticals | 164.21M |
| Tiziana Life Sciences | 160.81M |
| Agenus | 160.12M |
| ProQR Therapeutics | 159.10M |
| Galectin Therapeutics | 156.67M |
| Spero Therapeutics | 156.31M |
| Spruce Biosciences | 154.52M |